We testified that miR-224 targeted the 3’-UTR of SIRT3, suggesting that miR-224 functioned its oncogenic effects by negatively regulating SIRT3, a tumor-suppressive gene in NSCLC. This evidence concerns the gene SIRT3 and non-small cell lung carcinoma.